ImmuCell ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 For Immediate Release PORTLAND, Maine - April 2, 2020 - ImmuCell Corporation (Nasdaq: ICCC) ("ImmuCell" or the "Company"), a growing animal health company that develops, manufactures and markets scientifically-provenand practical products that improve the health and productivity of dairy and beef cattle, today announced preliminary, unaudited product sales results for the first quarter ended March 31, 2020. Product Sales Results: Total product sales increased by approximately 11.3%, or $500,000, to approximately $4.9 million during the quarter ended March 31, 2020...
|
